Journal article
Barriers to Intravenous Penicillin Use for Treatment of Nonmeningitis Pneumococcal Disease
Journal of clinical microbiology, Vol.48(9), pp.3372-3374
09/2010
DOI: 10.1128/JCM.01012-10
PMCID: PMC2937691
PMID: 20610674
Abstract
Infectious disease physicians were surveyed to determine whether the new penicillin breakpoint change will translate into increased penicillin use and to identify barriers to intravenous (i.v.) penicillin use for pneumococcal infections. The inconvenience of i.v. penicillin may limit its use despite a reduction in numbers of infections considered resistant.
Details
- Title: Subtitle
- Barriers to Intravenous Penicillin Use for Treatment of Nonmeningitis Pneumococcal Disease
- Creators
- Jennifer Rosen - Centers for Disease Control and Prevention, Atlanta, GeorgiaSusan Beekmann - Centers for Disease Control and Prevention, Atlanta, GeorgiaPhilip Polgreen - Centers for Disease Control and Prevention, Atlanta, GeorgiaMatthew Moore - Centers for Disease Control and Prevention, Atlanta, Georgia
- Resource Type
- Journal article
- Publication Details
- Journal of clinical microbiology, Vol.48(9), pp.3372-3374
- DOI
- 10.1128/JCM.01012-10
- PMID
- 20610674
- PMCID
- PMC2937691
- NLM abbreviation
- J Clin Microbiol
- ISSN
- 0095-1137
- eISSN
- 1098-660X
- Publisher
- American Society for Microbiology (ASM)
- Language
- English
- Date published
- 09/2010
- Academic Unit
- Infectious Diseases; Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984094387202771
Metrics
25 Record Views